Haemonetics Pre-Tax Profit Margin 2012-2025 | HAE
Haemonetics pre-tax profit margin from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Haemonetics Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-12-31 | $1.32B | $0.23B | 17.22% |
| 2025-09-30 | $1.33B | $0.22B | 16.34% |
| 2025-06-30 | $1.35B | $0.21B | 15.66% |
| 2025-03-31 | $1.36B | $0.21B | 15.64% |
| 2024-12-31 | $1.37B | $0.17B | 12.01% |
| 2024-09-30 | $1.36B | $0.16B | 11.68% |
| 2024-06-30 | $1.33B | $0.15B | 11.03% |
| 2024-03-31 | $1.31B | $0.15B | 11.62% |
| 2023-12-31 | $1.27B | $0.16B | 12.77% |
| 2023-09-30 | $1.24B | $0.16B | 12.92% |
| 2023-06-30 | $1.22B | $0.17B | 13.80% |
| 2023-03-31 | $1.17B | $0.14B | 12.08% |
| 2022-12-31 | $1.13B | $0.12B | 10.90% |
| 2022-09-30 | $1.08B | $0.11B | 10.34% |
| 2022-06-30 | $1.03B | $0.09B | 8.87% |
| 2022-03-31 | $0.99B | $0.06B | 6.34% |
| 2021-12-31 | $0.95B | $0.02B | 2.20% |
| 2021-09-30 | $0.93B | $0.03B | 2.89% |
| 2021-06-30 | $0.90B | $0.06B | 6.87% |
| 2021-03-31 | $0.87B | $0.07B | 8.39% |
| 2020-12-31 | $0.88B | $0.12B | 13.82% |
| 2020-09-30 | $0.90B | $0.12B | 13.64% |
| 2020-06-30 | $0.95B | $0.11B | 11.95% |
| 2020-03-31 | $0.99B | $0.09B | 8.81% |
| 2019-12-31 | $1.00B | $0.09B | 8.71% |
| 2019-09-30 | $0.99B | $0.07B | 7.50% |
| 2019-06-30 | $0.98B | $0.05B | 5.33% |
| 2019-03-31 | $0.97B | $0.07B | 7.55% |
| 2018-12-31 | $0.95B | $0.06B | 6.72% |
| 2018-09-30 | $0.94B | $0.04B | 4.15% |
| 2018-06-30 | $0.92B | $0.04B | 4.23% |
| 2018-03-31 | $0.90B | $0.06B | 6.53% |
| 2017-12-31 | $0.90B | $-0.01B | -1.45% |
| 2017-09-30 | $0.89B | $0.01B | 0.67% |
| 2017-06-30 | $0.89B | $0.01B | 0.68% |
| 2017-03-31 | $0.89B | $-0.03B | -3.05% |
| 2016-12-31 | $0.90B | $0.02B | 2.67% |
| 2016-09-30 | $0.91B | $-0.06B | -6.41% |
| 2016-06-30 | $0.91B | $-0.06B | -7.07% |
| 2016-03-31 | $0.91B | $-0.05B | -5.73% |
| 2015-12-31 | $0.89B | $-0.03B | -3.81% |
| 2015-09-30 | $0.89B | $0.05B | 5.05% |
| 2015-06-30 | $0.90B | $0.04B | 4.23% |
| 2015-03-31 | $0.91B | $0.03B | 3.52% |
| 2014-12-31 | $0.93B | $0.03B | 3.46% |
| 2014-09-30 | $0.94B | $0.03B | 3.32% |
| 2014-06-30 | $0.94B | $0.04B | 4.45% |
| 2014-03-31 | $0.94B | $0.04B | 3.94% |
| 2013-12-31 | $0.95B | $0.04B | 4.43% |
| 2013-09-30 | $0.95B | $0.04B | 4.20% |
| 2013-06-30 | $0.94B | $0.03B | 2.99% |
| 2013-03-31 | $0.89B | $0.05B | 5.61% |
| 2012-12-31 | $0.83B | $0.06B | 6.76% |
| 2012-09-30 | $0.77B | $0.07B | 8.81% |
| 2012-06-30 | $0.73B | $0.08B | 10.64% |
| 2012-03-31 | $0.73B | $0.09B | 12.23% |
| 2011-12-31 | $0.71B | $0.10B | 13.64% |
| 2011-09-30 | $0.70B | $0.10B | 14.35% |
| 2011-06-30 | $0.69B | $0.11B | 16.06% |
| 2011-03-31 | $0.68B | $0.11B | 16.25% |
| 2010-12-31 | $0.68B | $0.09B | 12.57% |
| 2010-09-30 | $0.66B | $0.08B | 12.35% |
| 2010-06-30 | $0.65B | $0.08B | 12.08% |
| 2010-03-31 | $0.65B | $0.08B | 12.56% |
| 2009-12-31 | $0.63B | $0.10B | 15.13% |
| 2009-09-30 | $0.62B | $0.09B | 15.05% |
| 2009-06-30 | $0.61B | $0.09B | 14.83% |
| 2009-03-31 | $0.60B | $0.08B | 14.07% |
| 2008-12-31 | $0.58B | $0.09B | 14.90% |
| 2008-09-30 | $0.56B | $0.09B | 15.07% |
| 2008-06-30 | $0.54B | $0.08B | 14.66% |
| 2008-03-31 | $0.52B | $0.08B | 14.89% |
| 2007-12-31 | $0.50B | $0.08B | 16.97% |
| 2007-09-30 | $0.47B | $0.08B | 17.30% |
| 2007-06-30 | $0.46B | $0.07B | 15.62% |
| 2007-03-31 | $0.45B | $0.07B | 15.78% |
| 2006-12-31 | $0.44B | $0.07B | 15.58% |
| 2006-09-30 | $0.44B | $0.09B | 21.61% |
| 2006-06-30 | $0.43B | $0.10B | 24.12% |
| 2006-03-31 | $0.42B | $0.11B | 25.30% |
| 2005-12-31 | $0.41B | $0.10B | 23.47% |
| 2005-09-30 | $0.40B | $0.07B | 16.96% |
| 2005-06-30 | $0.39B | $0.07B | 16.84% |
| 2005-03-31 | $0.38B | $0.06B | 15.63% |
| 2004-12-31 | $0.38B | $0.06B | 15.45% |
| 2004-09-30 | $0.38B | $0.06B | 15.47% |
| 2004-06-30 | $0.37B | $0.05B | 14.29% |
| 2004-03-31 | $0.36B | $0.05B | 12.91% |
| 2003-12-31 | $0.35B | $0.04B | 11.24% |
| 2003-09-30 | $0.34B | $0.04B | 10.50% |
| 2003-06-30 | $0.34B | $0.04B | 10.79% |
| 2003-03-31 | $0.34B | $0.04B | 11.57% |
| 2002-12-31 | $0.34B | $0.04B | 12.84% |
| 2002-09-30 | $0.33B | $0.03B | 10.24% |
| 2002-06-30 | $0.33B | $0.04B | 11.66% |
| 2002-03-31 | $0.32B | $0.04B | 12.19% |
| 2001-12-31 | $0.32B | $0.04B | 11.67% |
| 2001-09-30 | $0.31B | $0.05B | 14.89% |
| 2001-06-30 | $0.30B | $0.02B | 6.35% |
| 2001-03-31 | $0.29B | $0.02B | 5.80% |
| 2000-12-31 | $0.29B | $0.01B | 3.14% |
| 2000-09-30 | $0.28B | $0.01B | 2.48% |
| 2000-06-30 | $0.28B | $0.03B | 10.04% |
| 2000-03-31 | $0.28B | $0.03B | 10.07% |
| 1999-12-31 | $0.28B | $0.04B | 12.77% |
| 1999-09-30 | $0.28B | $0.03B | 11.83% |
| 1999-06-30 | $0.28B | $0.03B | 11.83% |
| 1999-03-31 | $0.28B | $0.03B | 11.35% |
| 1998-12-31 | $0.27B | $0.03B | 10.70% |
| 1998-09-30 | $0.27B | $0.00B | 1.47% |
| 1998-06-30 | $0.28B | $0.00B | 0.72% |
| 1998-03-31 | $0.29B | $0.00B | 1.40% |
| 1997-12-31 | $0.30B | $0.01B | 3.30% |
| 1997-09-30 | $0.31B | $0.04B | 12.70% |
| 1997-06-30 | $0.31B | $0.05B | 14.98% |
| 1997-03-31 | $0.30B | $0.05B | 16.50% |
| 1996-12-31 | $0.29B | $0.05B | 17.81% |
| 1996-09-30 | $0.29B | $0.06B | 19.10% |
| 1996-06-30 | $0.28B | $0.06B | 19.72% |
| 1996-03-31 | $0.28B | $0.06B | 19.78% |
| 1995-12-31 | $0.28B | $0.05B | 19.57% |
| 1995-09-30 | $0.27B | $0.05B | 19.49% |
| 1995-06-30 | $0.27B | $0.05B | 19.78% |
| 1995-03-31 | $0.26B | $0.05B | 20.23% |
| 1994-12-31 | $0.26B | $0.05B | 20.93% |
| 1994-09-30 | $0.26B | $0.05B | 21.18% |
| 1994-06-30 | $0.25B | $0.05B | 20.95% |
| 1994-03-31 | $0.25B | $0.05B | 20.48% |
| 1993-12-31 | $0.24B | $0.05B | 19.83% |
| 1993-09-30 | $0.24B | $0.05B | 19.49% |
| 1993-06-30 | $0.23B | $0.04B | 19.03% |
| 1993-03-31 | $0.22B | $0.04B | 18.52% |
| 1992-12-31 | $0.21B | $0.04B | 18.36% |
| 1992-09-30 | $0.20B | $0.03B | 17.44% |
| 1992-06-30 | $0.19B | $0.03B | 16.76% |
| 1992-03-31 | $0.18B | $0.03B | 15.91% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.684B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |